Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences Track

Spatial covariance pattern of α4β2 nicotinic cholinergic receptors ([18F]flubatine) in Parkinson disease

Martijn Muller, Siamak Nejad-Davarani and Nicolaas Bohnen
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1833;
Martijn Muller
1Radiology University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siamak Nejad-Davarani
1Radiology University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolaas Bohnen
1Radiology University of Michigan Ann Arbor MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1833

Objectives In vivo brain PET shows widespread reduction of α4β2 nicotinic cholinergic receptor (nAChR) expression in Parkinson disease (PD). However, less is known about changes in functional and structural connections of α4β2 nAChRs expression in PD. We used spatial covariance analysis (SCA) to explore the cerebral change in the spatial covariance pattern of [18F]flubatine PET, a high affinity and specificity α4β2 nAChR ligand, relative to normal controls (NC).

Methods Cross-sectional study. 27 (20 PD; 7 NC) subjects underwent [18F]flubatine brain PET. Images were spatially normalized to a PET template. Multivariate spatial covariance analysis based on the scaled subprofile model was performed simultaneously on all images using the generalized covariance analysis software suit (http://www.nitrc.org/projects/gcva_pca/) in order to identify between-group variations as a spatial covariance pattern (SCP). The MDS-UPDRS, a PD disease symptom severity neurological assessment scale, was performed in the dopaminergic “off” state.

Results SCP analysis showed a strong pattern of negative weights in the cerebellum. The mean subject scaling factor (SSF) score, representing the extent to which each subject expressed the SCP, was significantly higher in PD than in NC (13.0 ± 11.7 vs.-2.4 ± 9.6; t=-3.1, p=0.004). For PD patients, SSF did not correlate with age, disease duration, or disease symptom severity; however, it did correlate with absolute [18F]flubatine binding in the cerebellum (r=-0.677, p=0.001) and the pons (r=-0.574, p=0.008).

Conclusions The multivariate SCA approach identified a SCP with the cerebellum as a region of concomitant down-regulation of α4β2 nAChRs in PD patients. However, the strength of this effect for individual PD patients (SSF) was not related to PD disease characteristics. The lack of significant clinical correlation of this downregulation may represent a PD-specific mechanism that will need to be further explored in longitudinal studies.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Spatial covariance pattern of α4β2 nicotinic cholinergic receptors ([18F]flubatine) in Parkinson disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Spatial covariance pattern of α4β2 nicotinic cholinergic receptors ([18F]flubatine) in Parkinson disease
Martijn Muller, Siamak Nejad-Davarani, Nicolaas Bohnen
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1833;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Spatial covariance pattern of α4β2 nicotinic cholinergic receptors ([18F]flubatine) in Parkinson disease
Martijn Muller, Siamak Nejad-Davarani, Nicolaas Bohnen
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1833;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences Track

  • Impact of cognitive reserve in frontotemporal dementia illustrated by FDG-PET.
  • Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with 18F-FEOBV
  • Kinetic evaluation of [18F]MOZAT PET imaging in humans.
Show more Neurosciences Track

MTA II: Neurology Posters

  • Correlation of metabolic and volumetric metrics of the structures of the temporal lobe on MRI and FDG-PET in patients with mesial temporal sclerosis
  • Performance of 18F-Florbetaben PET Image Reading Training in Japanese language.
  • Radiolabeling, Characterization and Diagnostic imaging of 99mTc-TRODAT-1 SPECT-CT in Parkinson disease
Show more MTA II: Neurology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire